Dubai: The Ministry of Health and Prevention (MoHAP) has issued a circular withdrawing batch No.0093 of the pharmaceutical product (Laxocodyl suppositories10mg) after finding a mistake on the outside label.
The medicine label contained incorrect information citing that the drug is for children” instead of “for adults”, making the dose unsafe for children, which could result in them having a double dose and suffering side effects.
The medicine was reportedly used for the treatment of constipation for adults and is manufactured by Julphar Gulf Pharmaceutical Industries Manufacturers In the form of suppositories.
As per the circular, the medicine, which is registered with the ministry’s Drug Administration, will be withdrawn from the UAE market. All healthcare practitioners were advised not to use the medicine and all pharmacies were ordered not to dispense the medicine and to return it to the supplier.
RIYADH, June 2 – Ellora Group, a leading Doha-based distributor of building materials and industrial fasteners,…
DUBAI – President Donald Trump’s recently concluded visit to the Gulf Cooperation Council (GCC) countries has…
DUBAI – Dubai’s music scene is set to sizzle this June with a lineup of international…
DUBAI – The United Arab Emirates is set to host a vibrant array of events this…
ABU DHABI– Etihad Airways, the national airline of the United Arab Emirates, has entered into…
RIO DE JANEIRO – Carlo Ancelotti has officially arrived in Brazil to commence his role as…
